A detailed history of Mrp Capital Investments, LLC transactions in Amgen Inc stock. As of the latest transaction made, Mrp Capital Investments, LLC holds 700 shares of AMGN stock, worth $196,007. This represents 0.21% of its overall portfolio holdings.

Number of Shares
700
Previous 700 -0.0%
Holding current value
$196,007
Previous $219 Million 3.12%
% of portfolio
0.21%
Previous 0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$262.75 - $319.31 $183,925 - $223,517
700 New
700 $219 Million
Q4 2023

Jan 29, 2024

BUY
$255.7 - $288.46 $63,925 - $72,115
250 Added 23.81%
1,300 $374 Million
Q3 2023

Nov 02, 2023

SELL
$218.65 - $271.46 $16,398 - $20,359
-75 Reduced 6.67%
1,050 $282 Million
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $45,158 - $55,040
200 Added 21.62%
1,125 $272 Million
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $211,852 - $269,184
925 New
925 $243 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mrp Capital Investments, LLC Portfolio

Follow Mrp Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mrp Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mrp Capital Investments, LLC with notifications on news.